|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.032 HKD | 0.00% |
|
0.00% | -11.11% |
| May. 02 | Active Gains Files Winding-Up Petition Against Kontafarma China's Subsidiary | MT |
| Apr. 19 | Kontafarma China Holdings Limited Announces Management Changes, Effect from 19 April 2024 | CI |
Tongfang Kontafarma Holdings Limited reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was HKD 451.09 million compared to HKD 385.06 million a year ago. Net loss was HKD 31.18 million compared to HKD 75.5 million a year ago.
Basic loss per share from continuing operations was HKD 0.0092 compared to HKD 0.016 a year ago. Basic loss per share was HKD 0.0056 compared to HKD 0.0135 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -11.11% | 22.89M | |
| +21.85% | 546B | |
| -4.77% | 359B | |
| +16.97% | 323B | |
| +5.69% | 290B | |
| +13.68% | 234B | |
| +3.65% | 198B | |
| -11.12% | 194B | |
| +8.08% | 167B | |
| -3.40% | 157B |
KONTAFARMA CHINA HOLDINGS LIMITED 
